Brics Biomed centres to be set up in 4 Indian cities by 2025

BRICS-Biomed, Cardiology Research Institute, Tomsk NRMC, Russia Chairman Shamil Akhmedov, said that the main aim of creation of the BRICS-Biomed Consortium is the development of new biomedical technologies for diagnosis and treatment of human diseases, development of domestic demand and export of biotech products, creation of technological base for new biotech areas of industrial sector.

While addressing the country seminar ‘BRICS-Biomed Consortium: The First Results and Prospects of Future Development’ at the BRICS Trade Fair, Akhmedov said that the objectives of the consortium were promotion of expertise on innovative projects with respect to the technological feasibility and commercial potential of R&D; conductance of marketing studies, accumulation of information on market demands in particular innovative technological solutions.

Associate BRICS-Biomed (India- Academic) Chairman S G Prakash Vincent, said that the aim of the consortium is to provide affordable and novel medicines.